Maternal-Fetal Medicine (Jul 2022)

A Summary of Chinese Expert Consensus on Fetal Growth Restriction (An Update on the 2019 Version)

  • Fetal Medicine Subgroup, Chinese Society of Perinatal Medicine, Chinese Medical Association; Maternal-Fetal Medicine Committee, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association,
  • Luming Sun,
  • Yali Hu,
  • Hongbo Qi,
  • Dandan Shi

DOI
https://doi.org/10.1097/FM9.0000000000000158
Journal volume & issue
Vol. 4, no. 3
pp. 162 – 168

Abstract

Read online

Abstract. Fetal growth restriction (FGR) is a common complication of pregnancy associated with higher rates of perinatal mortality and morbidity, as well as a variety of long-term adverse outcomes. To standardize the clinical practice for the management of FGR in China, Fetal Medicine Subgroup, Chinese Society of Perinatal Medicine, Chinese Medical Association and Maternal-Fetal Medicine Committee, Chinese Society of Obstetrics and Gynecology,Chinese Medical Association organized an expert committee to provide official consensus-based recommendations on FGR. We evaluated the evidence provided by relevant high-quality literature, performed a three-round Delphi study and organized face-to-face meetings with experts from multidisciplinary backgrounds. The consensus includes the definition, prenatal screening, prevention, diagnosis, monitoring and management of FGR.